Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N J Hart

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cytotherapy|June 19, 2004
Loading DCs with AgF Vari, D N J Hart
Current Drug Targets|January 24, 2004
Dendritic cells in tumor immunology and immunotherapyC J Turtle, D N J Hart
Current Pharmaceutical Design|June 19, 2002
Growth factors, cytokines and dendritic cell developmentS Vuckovic, G J Clark, D N J Hart
Cytotherapy|June 19, 2004
DC preparations for therapyA M Rice, K L Jones, D N J Hart
Stem Cells and Development|November 15, 2007
Cord blood CD34+ cells cultured with FLT3L, stem cell factor, interleukin-6, and IL-3 produce CD11c+CD1a-/c- myeloid dendritic cellsS A W Fadilah, S Vuckovic, D Khalil, et al.
British Journal of Cancer|March 1, 2002
Dendritic cell density and activation status in human breast cancer -- CD1a, CMRF-44, CMRF-56 and CD-83 expressionB J Coventry, P-L Lee, D Gibbs, et al.
Cytotherapy|June 19, 2004
DC in multiple myeloma immunotherapyC J Turtle, R D Brown, D E Joshua, et al.
Journal of Biological Regulators and Homeostatic Agents|November 29, 2002
CMRF-35A, CMRF-35H: potential new CDG J Clark, S Fitzpatrick, B Kuo, et al.
Oral Microbiology and Immunology|December 18, 2002
Antigen-presenting cells in human periodontal disease tissuesE Gemmell, C L Carter, D N J Hart, et al.
Cytotherapy|June 19, 2004
The immune response to breast cancer, and the case for DC immunotherapyC P Allan, C J Turtle, P N Mainwaring, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cytotherapy|June 19, 2004
Loading DCs with AgF Vari, D N J Hart
Current Drug Targets|January 24, 2004
Dendritic cells in tumor immunology and immunotherapyC J Turtle, D N J Hart
Current Pharmaceutical Design|June 19, 2002
Growth factors, cytokines and dendritic cell developmentS Vuckovic, G J Clark, D N J Hart
Cytotherapy|June 19, 2004
DC preparations for therapyA M Rice, K L Jones, D N J Hart
Stem Cells and Development|November 15, 2007
Cord blood CD34+ cells cultured with FLT3L, stem cell factor, interleukin-6, and IL-3 produce CD11c+CD1a-/c- myeloid dendritic cellsS A W Fadilah, S Vuckovic, D Khalil, et al.
British Journal of Cancer|March 1, 2002
Dendritic cell density and activation status in human breast cancer -- CD1a, CMRF-44, CMRF-56 and CD-83 expressionB J Coventry, P-L Lee, D Gibbs, et al.
Cytotherapy|June 19, 2004
DC in multiple myeloma immunotherapyC J Turtle, R D Brown, D E Joshua, et al.
Journal of Biological Regulators and Homeostatic Agents|November 29, 2002
CMRF-35A, CMRF-35H: potential new CDG J Clark, S Fitzpatrick, B Kuo, et al.
Oral Microbiology and Immunology|December 18, 2002
Antigen-presenting cells in human periodontal disease tissuesE Gemmell, C L Carter, D N J Hart, et al.
Cytotherapy|June 19, 2004
The immune response to breast cancer, and the case for DC immunotherapyC P Allan, C J Turtle, P N Mainwaring, et al.
Pageof 2